MiNK Therapeutics, Inc. (INKT) Financials
INKT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 7.5 million | 21.0 million |
| 2023-06-30 | 12.1 million | 21.6 million |
| 2023-03-31 | 16.6 million | 21.1 million |
| 2022-12-31 | 21.5 million | 21.9 million |
INKT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -4.2 million | 939264 |
| 2023-06-30 | -4.2 million | 898265 |
| 2023-03-31 | -4.4 million | 921139 |
| 2022-12-31 | -4.6 million | 667631 |
INKT Net Income
No data available :(
INKT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 6.4 million | - | - |
| 2023-06-30 | 10.6 million | - | - |
| 2023-03-31 | 14.9 million | - | - |
| 2022-12-31 | 19.6 million | - | - |
INKT Shares Outstanding
INKT Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 23043 | 3.4 million | 1.8 million | - |
| 2023-06-30 | 37018 | 4.6 million | 1.8 million | - |
| 2023-03-31 | 13500 | 4.2 million | 1.7 million | - |
| 2022-12-31 | 127838 | 5.8 million | 2.1 million | - |
INKT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 5.2 billion |
| 2023-06-30 | - | 6.3 billion |
| 2023-03-31 | 11.7 billion | 5.9 billion |
| 2022-12-31 | 2.7 billion | 37933 |
INKT
Price: $0.98
52 week price:
Earnings Per Share: -0.65 USD
P/E Ratio: -1.25
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 4128
Market Capitalization: 34.2 million